Literature DB >> 19041609

What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?

Claudio Anasetti1.   

Abstract

Several recipient and donor risk factors affect outcome after transplantation with allogeneic hematopoietic stem cells. The most important recipient risk factors are patient age, comorbidity, performance status, cytomegalovirus (CMV) status, and disease considerations, such as diagnosis, stage, and cytogenetic risk. Prior chemotherapy regimens, patient race, and IL10 promoter polymorphism also appear to have some impact, but to a lesser extent. The most important donor factor is the level of HLA mismatch. Donor gender, relation, age, and KIR genotype also affect outcome. Donor CMV serology, parity, and race do not appear to affect outcome. These factors must all be considered in relation to one another when selecting whether to recommend patients for transplant.

Entities:  

Mesh:

Year:  2008        PMID: 19041609      PMCID: PMC3470825          DOI: 10.1016/j.beha.2008.10.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  20 in total

1.  IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

Authors:  Lidia Karabon; Barbara Wysoczanska; Katarzyna Bogunia-Kubik; Krzysztof Suchnicki; Andrzej Lange
Journal:  Hum Immunol       Date:  2005-03-19       Impact factor: 2.850

2.  Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

Authors:  K Scott Baker; Fausto R Loberiza; Hongmei Yu; Mitchell S Cairo; Brian J Bolwell; Willem A Bujan-Boza; Bruce M Camitta; Juan Jose Garcia; Winston G Ho; Jane L Liesveld; Dipnarine Maharaj; David I Marks; Kirk R Schultz; Peter Wiernik; Axel R Zander; Mary M Horowitz; Armand Keating; Daniel J Weisdorf
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

3.  Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

Authors:  C Kollman; C W Howe; C Anasetti; J H Antin; S M Davies; A H Filipovich; J Hegland; N Kamani; N A Kernan; R King; V Ratanatharathorn; D Weisdorf; D L Confer
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

4.  Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada.

Authors:  Derek S Serna; Stephanie J Lee; Mei-jie Zhang; k Scott Baker; Mary Eapen; Mary M Horowitz; John P Klein; J Douglas Rizzo; Fausto R Loberiza
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

5.  Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.

Authors:  Ming-Tseh Lin; Barry Storer; Paul J Martin; Li-Hui Tseng; Ted Gooley; Pei-Jer Chen; John A Hansen
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

6.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

7.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Authors:  Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

Review 8.  Alloreactive killer cells: hindrance and help for haematopoietic transplants.

Authors:  Peter Parham; Karina L McQueen
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

9.  Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.

Authors:  Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Pulsipher; Peter A McSweeney; Rainer Storb
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

10.  A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Authors:  Corey S Cutler; Stephanie J Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

View more
  11 in total

1.  Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients.

Authors:  Natalia Maximova; Giulia Caddeo; Davide Zanon; Alessandra Maestro; Roberto Simeone
Journal:  J Clin Med       Date:  2019-06-10       Impact factor: 4.241

Review 2.  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

Authors:  Ulas D Bayraktar; Joseph L Nates
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 3.  The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

Authors:  Jan J Cornelissen; Alois Gratwohl; Richard F Schlenk; Jorge Sierra; Martin Bornhäuser; Gunnar Juliusson; Zdenek Råcil; Jacob M Rowe; Nigel Russell; Mohamad Mohty; Bob Löwenberg; Gerard Socié; Dietger Niederwieser; Gert J Ossenkoppele
Journal:  Nat Rev Clin Oncol       Date:  2012-09-04       Impact factor: 66.675

Review 4.  Stem cells and neuroprotection: understanding the players.

Authors:  Virginia Pearce
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

5.  Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.

Authors:  Johan Maertens; Aaron C Logan; Junho Jang; Gwynn Long; Jih-Luh Tang; William Y K Hwang; Liang Piu Koh; Roy Chemaly; Armin Gerbitz; Julia Winkler; Su-Peng Yeh; John Hiemenz; Sandra Christoph; Dong-Gun Lee; Po-Nan Wang; Ernst Holler; Stephan Mielke; Luke Akard; Adeline Yeo; Sangana Ramachandra; Kristin Smith; Peter Pertel; Florencia Segal
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

6.  Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies.

Authors:  Erik Rupnik; Matevz Skerget; Matjaz Sever; Irena Preloznik Zupan; Maja Ogrinec; Barbara Ursic; Natasa Kos; Peter Cernelc; Samo Zver
Journal:  BMC Cancer       Date:  2020-11-24       Impact factor: 4.430

7.  Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation.

Authors:  Esteban Arrieta-Bolaños; J Alejandro Madrigal; Bronwen E Shaw
Journal:  Bone Marrow Res       Date:  2012-11-18

Review 8.  Tissue resident stem cells: till death do us part.

Authors:  Hadas Raveh-Amit; Sara Berzsenyi; Virag Vas; Danna Ye; Andras Dinnyes
Journal:  Biogerontology       Date:  2013-10-02       Impact factor: 4.277

9.  Predictors and Outcome of Pericardial Effusion After Hematopoietic Stem Cell Transplantation in Children.

Authors:  A B Versluys; H B Grotenhuis; M J J Boelens; A M C Mavinkurve-Groothuis; J M P J Breur
Journal:  Pediatr Cardiol       Date:  2017-10-23       Impact factor: 1.655

10.  Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors-Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses.

Authors:  Tor Henrik Anderson Tvedt; Guro K Melve; Galina Tsykunova; Aymen Bushra Ahmed; Annette K Brenner; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2018-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.